Skip to content
OpenCapital
Get started

Treace Medical Concepts, Inc. TMCI Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$47.4MMiss by $2.5M
EPS-$0.28Beat by $0.01
Revenue estimate$49.9M
EPS estimate-$0.29

Next report

Aug 7, 2026 (In 1 week)
Revenue estimate$44.0M
EPS estimate-$0.30

Financials

Q2 2025

Income statement

See full
Revenue$47.4M+6.6%
Gross profit$37.8M+5.8%
Operating income-$17.0M+20.6%
Net income-$17.4M+18.0%
EPS (diluted)-$0.28+17.6%

Balance sheet

See full
Cash & equivalents$8.1M-55.7%
Total debt$70.1M+0.3%
Total equity$97.6M-13.0%
Total assets$206.4M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+78.1%
CapEx$4.8M+176%
Free cash flow-$7.8M+50.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$372.4M-9.4%
Enterprise value$434.44M-6.1%
P/S1.7×-0.3×

Profitability

See full
Gross margin80.1%-0.6pp
Operating margin-22.4%-5.4pp
Net margin-23%-5.1pp
FCF margin-13.6%-3.5pp

Returns & leverage

See full
Return on equity-46.9%-1.6pp
Debt / equity0.7×+0.1×
Current ratio3.5×-0.3×

Versus estimates

Revenue

Q1 2026$47.2MBeat by $1.2MQ4 2025$62.5MBeat by $670.3KQ3 2025$50.2MMiss by $11.5M
Q2 2025$47.4MMiss by $2.5M
Q1 2025$52.6MBeat by $3.1MQ4 2024$68.7MBeat by $1.5M

Diluted EPS

Q1 2026-$0.28Beat by $0.03Q4 2025-$0.12Beat by $0.03Q3 2025-$0.26Beat by $0.02
Q2 2025-$0.28Beat by $0.01
Q1 2025-$0.25Beat by $0.06Q4 2024-$0.01Beat by $0.03

Ask the moment Treace Medical Concepts, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Treace Medical Concepts, Inc. report Q2 2025 earnings?
Treace Medical Concepts, Inc. (TMCI) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Treace Medical Concepts, Inc.'s Q2 2025 revenue and EPS?
Treace Medical Concepts, Inc. reported revenue of $47.4M and eps of $-0.28 for Q2 2025.
Did Treace Medical Concepts, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $49.9M by $2.5M. EPS beat the consensus estimate of $-0.29 by $0.01.
How did Treace Medical Concepts, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.6% from $44.5M a year earlier and eps grew 17.6% from $-0.34.
Where can I find Treace Medical Concepts, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-105059) directly on SEC EDGAR. The filing index links above go to sec.gov.